Ikarian Capital, LLC Immunovant, Inc. Transaction History

Ikarian Capital, LLC

$754 Million
Q1 2024

A detailed history of Ikarian Capital, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 276,925 shares of IMVT stock, worth $7.62 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares

276,925

Previous 276,925 -0.0%

Holding current value

$7.62 Million

Previous $8.95 Million -0.0%

% of portfolio

1.19%

Previous 1.18%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$30.27 - $43.79 $1.32 Million - $1.91 Million	43,531 Added 18.65%	276,925 $8.95 Million
Q4 2023 Feb 14, 2024	SELL	$31.31 - $44.19 $2.02 Million - $2.85 Million	-64,400 Reduced 21.63%	233,394 $9.83 Million
Q3 2023 Nov 14, 2023	BUY	$18.55 - $39.96 $5.52 Million - $11.9 Million	297,794 New	297,794 $11.4 Million
Q1 2023 May 15, 2023	SELL	$15.27 - $19.72 $2.94 Million - $3.79 Million	-192,302 Reduced 19.89%	774,398 $12 Million
Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $1.02 Million - $2.75 Million	155,000 Added 19.1%	966,700 $17.2 Million

Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $3.19 Million - $5.17 Million	811,700 New	811,700 $4.53 Million
Q4 2021 Feb 14, 2022	SELL	$7.33 - $9.32 $608,727 - $773,988	-83,046 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.01 - $11.37 $718,202 - $1.16 Million	-102,454 Reduced 55.23%	83,046 $722,000
Q2 2021 Aug 16, 2021	SELL	$9.4 - $16.85 $470,817 - $843,965	-50,087 Reduced 21.26%	185,500 $1.96 Million
Q4 2020 Feb 12, 2021	SELL	$36.36 - $52.71 $3.14 Million - $4.55 Million	-86,300 Reduced 26.81%	235,587 $10.9 Million
Q3 2020 Nov 16, 2020	BUY	$22.61 - $38.9 $898,159 - $1.55 Million	39,724 Added 14.08%	321,887 $11.3 Million
Q2 2020 Aug 14, 2020	SELL	$13.87 - $28.44 $7.77 Million - $15.9 Million	-560,300 Reduced 66.51%	282,163 $6.87 Million
Q1 2020 May 15, 2020	BUY	$8.36 - $17.13 $2.83 Million - $5.8 Million	338,346 Added 67.12%	842,463 $13.1 Million
Q4 2019 Jan 31, 2020	BUY	$10.02 - $16.4 $5.05 Million - $8.27 Million	504,117 New	504,117 $8 Million

Others Institutions Holding IMVT

# of Institutions

238

Shares Held

62.9M

Call Options Held

1.46M

Put Options Held

546K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Account

Ikarian Capital, LLC Immunovant, Inc. Transaction History